CDH11 and breast carcinoma: We showed previously that the arthritis drug celecoxib had the structural potential to bind this pocket and now show that celecoxib, a celecoxib analogue with no COX-2 inhibitory activity, as well as several novel small molecules can selectively inhibit the growth of CDH11 expressing breast cancer cells [7].